Nanoparticles - Known and unknown health risks

Journal of Nanobiotechnology

Volumn 2, Issue , 2004, Pages

  Hoet, Peter H M ^a   Brüske Hohlfeld, Irene ^b   Salata, Oleg V ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON BLACK; CONSUMER PRODUCTS; HEALTH RISKS; MEDICAL IMAGING; NANOTECHNOLOGY; PLASTICS FILLERS; SILICA;

BIOLOGICAL IMAGING; HEALTH EFFECTS; INDUSTRIAL PRODUCTS; NANO-SCIENCES;

NANOSTRUCTURED MATERIALS;

2 DIETHYLAMINOETHANOL; CARBON; DOMIPHEN; FILLER; NANOPARTICLE; POLY(DIALLYLDIMETHYLAMMONIUM CHLORIDE); POLYETHYLENEIMINE; POLYGLACTIN; POLYLYSINE; QUANTUM DOT; SILICON DIOXIDE;

BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; BODY DISTRIBUTION; CELL DAMAGE; CONSUMER; DATA ANALYSIS; FLUORESCENCE ANALYSIS; GASTROINTESTINAL DISEASE; HEALTH HAZARD; HUMAN; LUNG DISEASE; MOTOR VEHICLE TIRE; NANOTECHNOLOGY; NONHUMAN; OXIDATIVE STRESS; PLASTIC INDUSTRY; QUANTITATIVE ANALYSIS; REVIEW; SKIN DISEASE; SURFACE CHARGE; TRANSPORT KINETICS;

EID: 13644259464     PISSN: 14773155     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-3155-2-12     Document Type: Review

References (116)

1. Feynman R: There's plenty of room at the bottom. Science 1991, 254:1300-1301.
2. Ball P: Roll-up for the revolution. Nature 2001, 414:142-144.
3. Salata OV: Application of nanoparticles in biology and medicine. J of Nanobiotechnology 2004, 2:3.
4. Mazzola L: Commercializing nanotechnology. Nature Biotechnology 2003, 21:1137-1143.
5. Paull R, Wolfe J, Hebert P, Sinkula M: Investing in nanotechnology. Nature Biotechnology 2003, 21:1134-1147.
6. NanoBusiness Alliance 2003 [http://www.nanobusiness.org].
7. Luther W, ed: Industrial application of nanomaterials - chances and risks. Future Technologies 2004, 54:1-112.
8. UK Royal Society and Royal Academy of Engineering: Nanoscience and nanotechnologies: opportunities and uncertainties. Final Report 2004 [http://www.nanotec.org.uk/finalReport.htm].
9. Anon: Nanotech is not so scary. Nature 2003, 421:299.
10. UK report: More Hits Than Misses on Nanotech Action Group on Erosion, Technology and Concentration (ETC) 2004 [http://www.etcgroup.org/documents/NR_RSfinreport.finaldoc.pdf].
11. Nemmar A, Vanbilloen H, Hoylaerts MF, Hoet PH, Verbruggen A, Nemery B: Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med 2001, 164:1665-1668.
12. Xiang JJ, Tang JQ, Zhu SG, Nie XM, Lu HB, Shen SR, Li XL, Tang K, Zhou M, Li GY: IONP-PLL: a novel non-viral vector for efficient gene delivery. J Gene Med 2003, 5:803-817.
13. Brown DM, Donaldson K, Borm PJ, Schins RP, Dehnhardt M, Gilmour P, Jimenez LA, Stone V: Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles. Am J Physiol Lung Cell Mol Physiol 2004, 286:L344-353.
14. Zheng M, Jagota A, Strano MS, Santos AP, Barone P, Chou CG, Diner BA, Dresselhaus MS, Mclean RS, Onoa GB, Samsonidze GG, Semke ED, Usrey M, Walls DJ: Structure-based carbon nanotube sorting by sequence-dependent DNA assembly. Science 2003, 302: 543-1548.
15. Moolgavkar SH, Brown RC, Turim J: Biopersistence, fiber length, and cancer risk assessment for inhaled fibers. Inhal Toxicol 2001, 13:755-772.
16. Lippmann M: Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect 1990, 88:311-317.
17. Moore MA, Brown RC, Pigott G: Material properties of MMVFs and their time-dependent failure in lung environments. Inhal Toxicol 2001, 13:1117-1149.
18. Oberdorster G: Determinants of the pathogenicity of manmade vitreous fibers (MMVF). Int Arch Occup Environ Health 2000, 73:S60-S68.
19. Oberdorster G: Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 2001, 74:1-8.
20. Oberdorster G: Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol 2002, 14:29-56.
21. Warheit DB, Hart GA, Hesterberg TW, Collins JJ, Dyer WM, Swaen GM, Castranova V, Soiefer AI, Kennedy GL: Potential pulmonary effects of man-made organic fiber (MMOF) dusts. Crit Rev Toxicol 2001, 31:697-736.
22. Service RF: Nanomaterials show signs of toxicity. Science 2003, 300:243.
23. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR: Comparative Pulmonary Toxicity Assessment of Single Wall Carbon Nanotubes in Rats. Toxicol Sci 2003, 77:117-125.
24. Lam CW, James JT, McCluskey R, Hunter RL: Pulmonary Toxicity of Single-Wall Carbon Nanotubes in Mice 7 and 90 Days after Intratracheal Instillation. Toxicol Sci 2003, 77:126-134.
25. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V: Exposure to Carbon Nanotube Material: Aerosol Release During the Handling of Unrefined Single Walled Carbon Nanotube Material. J Toxicol Environ Health 2004, 67:87-107.
26. Oberdorster G, Ferin J, Lehnert BE: Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 1994, 102:173-179.
27. Driscoll KE, Deyo LC, Carter JM, Howard BW, Hassenbein DG, Bertram TA: Effects of particle exposure and particle-elicited inflammatory cells on mutation in rat alveolar epithelial cells. Carcinogenesis 1997, 18:423-430.
28. Oberdorster G, Yu CP: Lung dosimetry - considerations for noninhalation studies. Exp Lung Res 1999, 25:1-6.
29. Heinrich U, Muhle H, Hoymann HG, Mermelstein R: Pulmonary function changes in rats after chronic and subchronic inhalation exposure to various particulate matter. Exp Pathol 1989, 37: 48-252.
30. Lee KP, Kelly DP, Schneider PW, Trochimowicz HJ: Inhalation toxicity study on rats exposed to titanium tetrachloride atmospheric hydrolysis products for two years. Toxicol Appl Pharmacol 1986, 83:30-45.
31. Lee KP, Kelly DP, Schneider PW, Trochimowicz HJ: Inhalation toxicity study on rats exposed to titanium tetrachloride atmospheric hydrolysis products for two years. Toxicol Appl Pharmacol 1986, 83:30-45.
32. Hoet PH, Gilissen L, Nemery B: Polyanions protect against the in vitro pulmonary toxicity of polycationic paint components associated with the Ardystil syndrome. Toxicol Appl Pharmacol 2001, 175:184-190.
33. Hoet PH, Gilissen LP, Leyva M, Nemery B: In vitro cytotoxicity of textile paint components linked to the "Ardystil syndrome". Toxicol Sci 1999, 52:209-216.
34. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T: In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003, 24: 121-1131.
35. Morgan DM, Clover J, Pearson JD: Effects of synthetic polycations on leucine incorporation, lactate dehydrogenase release, and morphology of human umbilical vein endothelial cells. J Cell Sci 1988, 91:231-238.
36. Morgan DM, Larvin VL, Pearson JD: Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells. J Cell Sci 1989, 94:553-559.
37. Haensler J, Szoka FC: Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem 1993, 4:372-379.
38. Fischer D, Bieber T, Li Y, Elsasser HP, Kissel T: A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999, 16:1273-1279.
39. Dekie L, Toncheva V, Dubruel P, Schacht EH, Barrett L, Seymour LW: Poly-L-glutamic acid derivatives as vectors for gene therapy. J Control Release 2000, 65:187-202.
40. Ryser HJ: A membrane effect of basic polymers dependent on molecular size. Nature 1967, 215:934-936.
41. Singh AK, Kasinath BS, Lewis EJ: Interaction of polycations with cell surface negative charges of epithelial cells. Biochim Biophys Acta 1992, 1120:337-342.
42. Geiser M, Schurch S, Gehr P: Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer. J Appl Physiol 2003, 94:1793-1801.
43. Gehr P, Geiser M, Hof VI, Schurch S: Surfactant ultrafine particle interactions: what we can learn from PM10 studies. Phil Trans R Soc Lond A 2000, 358:2707-2718.
44. Schins RP, Duffin R, Hohr D, Knaapen AM, Shi T, Weishaupt C, Stone V, Donaldson K, Borm PJ: Surface modification of quartz inhibits toxicity, particle uptake, and oxidative DNA damage in human lung epithelial cells. Chem Res Toxicol 2002, 15:1166-1173.
45. Fubini B: Surface Reactivity in the Pathogenic Response to Particulates. Environ Health Perspect 1997, 105:1013-1020.
46. Yeates DB, Mauderly JL: Inhaled environmental/occupational irritants and allergens: mechanisms of cardiovascular and systemic responses: Introduction. Environ Health Perspect 2001, 109: 79-481.
47. Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, Allen G, Verrier M, Cherry R, Verrier R: Ambient pollution and heart rate variability. Circulation 2000, 101:1267-1273.
48. Liao D, Creason J, Shy C, Williams R, Watts R, Zweidinger R: Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ Health Perspect 1999, 107:521-525.
49. Conhaim RL, Eaton A, Staub NC, Heath TD: Equivalent pore estimate for the alveolar-airway barrier in isolated dog lung. J Appl Physiol 1988, 64:1134-1142.
50. Hermans C, Knoops B, Wiedig M, Arsalane K, Toubeau G, Falmagne P, Bernard A: Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J 1999, 13:1014-1021.
51. Florence AT, Hussain N: Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Deliv Rev 2001, 50:S69-S89.
52. Brown JS, Zeman KL, Bennett WD: Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 2002, 166:1240-1247.
53. Kawakami K, Iwamura A, Goto E, Mori Y, Abe T, Hirasaw Y, Ishida H, Shimada T, Tominaga G: Kinetics and clinical application of 99mTc-technegas. Kaku Igaku 1990, 27:725-733.
54. Steiner S, Pfutzner A, Wilson BR, Harzer O, Heinemann L, Rave K: Technosphere/Insulin - proof of concept study with a new insulin formulation for pulmonary delivery. Exp Clin Endocrinol Diabetes 2002, 110:17-21.
55. Kreyling W, Semmler M, Erbe F, Mayer P, Schulz H, Oberdorster G, Ziesenis A: Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 2002, 65:1513-1530.
56. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C: Extrapulmonary translocation of ultrafine carbon particle following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002, 65:1531-1543.
57. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J: Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 2001, 109:547-551.
58. Eyles JE, Bramwell VW, Williamsson ED, Alpar HO: Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. Vaccine 2001, 19: 732-4742.
59. Kato T, Yashiro T, Murata Y, Herbert DC, Oshikawa K, Bando M, Ohno S, Sugiyama Y: Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries. Cell Tissue Res 2003, 311:47-51.
60. International Labour Organisation: Safety in the use of mineral and synthetic fibres; working document and report of the meeting of experts on safety in the use of mineral and synthetic fibres, Geneva, 17-25 April 1989. Occupational Safety and Health Series 1990, 64:1-94.
61. Searl A: A review of the durability of inhaled fibers and options for the design of safer fibers. Annals of Occupational Hygiene 1994, 38:839-855.
62. Stanton MF, Laynard M, Tegeris A, Miller E, May M, Kent E: Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst 1977, 58:587-603.
63. Stanton MF, Wrench C: Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst 1972, 48: 97-821.
64. Berman DW, Crump KS, Chatfield EJ, Davis JM, Jones AD: The sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Anal 1995, 15:181-195.
65. Schins RP: Mechanisms of genotoxicity of particles and fibers. Inhal Toxicol 2002, 14:57-78.
66. Hussain N, Jaitley V, Florence AT: Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 2001, 50:107-142.
67. Aprahamian M, Michel C, Humbert W, Devissaguet JP, Damge C: Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol Cell 1987, 61: 9-76.
68. Hillyer JF, Albrecht RM: Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 2001, 90:1927-1936.
69. Jani P, Halbert GW, Langridge J, Florence AT: The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol 1989, 41: 09-812.
70. Hussain N, Florence AT: Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles. Pharm Res 1998, 15:153-156.
71. Hussain N, Jani PU, Florence AT: Enhanced oral uptake of tomato lectin conjugated nanoparticles in the rat. Pharm Res 1997, 14:613-618.
72. Hillery AM, Jani PU, Florence AT: Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J Drug Target 1994, 2:151-156.
73. Woodley JF: Lectins for gastrointestinal targeting - 15 years on. J Drug Target 2000, 7:325-333.
74. Szentkuti L: Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon. J Control Release 1997, 46:233-242.
75. Jani P, Halbert GW, Langridge J, Florence AT: Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 1990, 42:821-826.
76. Lomer MC, Thompson RP, Powell JJ: Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc 2002, 61: 23-130.
77. Kucharzik T, Lugering A, Lugering N, Rautenberg K, Linnepe M, Cichon C, Reichelt R, Stoll R, Schmidt MA, Domschke W: Characterization of M cell development during indomethacin-induced ileitis in rats. Aliment Pharmacol Ther 2000, 14:247-256.
78. Powell JJ, Harvey RS, Ashwood P, Wolstencroft R, Gershwin ME, Thompson RP: Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun 2000, 14:99-105.
79. Hopwood D, Spiers EM, Ross PE, Anderson JT, McCullough JB, Murray FE: Endocytosis of fluorescent microspheres by human oesophageal epithelial cells: comparison between normal and inflamed tissue. Gut 1995, 37:598-602.
80. McMinn LH, Hodges GM, Carr KE: Gastrointestinal uptake and translocation of microparticles in the streptozotocin-diabetic rat. J Anat 1996, 189:553-559.
81. Limpanussorn J, Simon L, Dayan AD: Intestinal uptake of particulate material by dexamethasone-treated rats: use of a novel technique to avoid intestinal mucosal contamination. J Pharm Pharmacol 1998, 50:745-751.
82. Lademann J, Weigmann H, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W: Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 1999, 12: 47-256.
83. Kreilgaard M: Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 2002, 54:S77-S98.
84. Tinkle SS, Antonini JM, Rich BA, Roberts JR, Salmen R, DePree K, Adkins EJ: Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 2003, 111: 202-1208.
85. Menon GK, Elias PM: Morphologic basis for a pore-pathway in mammalian stratum corneum. Skin Pharmacol 1997, 10: 35-246.
86. Andersson KG, Fogh CL, Byrne MA, Roed J, Goddard AJ, Hotchkiss SA: Radiation dose implications of airborne contaminant deposition to humans. Health Phys 2002, 82:226-232.
87. Lademann J, Otberg N, Richter H, Weigmann HJ, Lindemann U, Schaefer H, Sterry W: Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol 2001, 14:17-22.
88. de Jalon EG, Blanco-Prieto MJ, Ygartua P, Santoyo S: PLGA microparticles: possible vehicles for topical drug delivery. Int J Pharm 2001, 226:181-184.
89. Blundell G, Henderson WJ, Price EW: Soil particles in the tissues of the foot in endemic elephantiasis of the lower legs. Ann Trop Med Parasitol 1989, 83:381-385.
90. Corachan M: Endemic Non-Filarial Elephantiasis of Lower-Limbs - Podoconiosis. Medicina Clinica 1988, 91: 7-100.
91. Verma DD, Verma S, Blume G, Fahr A: Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003, 258:141-151.
92. Saunders J, Davis H, Coetzee L, Botha S, Kruger A, Grobler A: A novel skin penetration enhancer: evaluation by membrane diffusion and confocal microscopy. J Pharm Pharm Sci 1999, 2:99-107.
93. Hostynek JJ: Factors determining percutaneous metal absorption. Food Chem Toxicol 2003, 41:327-345.
94. Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy RJ: Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J Pharm Sci 1998, 87:1229-1234.
95. Peters A, Dockery DW, Muller JE, Mittleman MA: Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001, 103:2810-2815.
96. Nemmar A, Hoylaerts MF, Hoet PH, Dinsdale D, Smith T, Xu H, Vermylen J, Nemery B: Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 2002, 166:998-1004.
97. Nemmar A, Hoylaerts MF, Hoet PH, Vermylen J, Nemery B: Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol 2003, 186:38-45.
98. Peters A, Doring A, Wichmann HE, Koenig W: Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 1997, 349:1582-1587.
99. Peters A, Liu E, Verrier RL, Schwartz J, Gold DR, Mittleman M, Baliff J, Oh JA, Allen G, Monahan K, Dockery DW: Air pollution and incidence of cardiac arrhythmia. Epidemiology 2000, 11: 1-17.
100. Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E: Nanocrystal targeting in vivo. Proc Natl Acad Sci US A 2002, 99:12617-12621.
101. Davda J, Labhasetwar V: Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 2002, 233:51-59.
102. Boland S, Baeza-Squiban A, Fournier T, Houcine O, Gendron MC, Chevrier M, Jouvenot G, Coste A, Aubier M, Marano F: Diesel exhaust particles are taken up by human airway epithelial cells in vitro and alter cytokine production. Am J Physiol 1999, 276: 604-L613.
103. Juvin P, Fournier T, Boland S, Soler P, Marano F, Desmonts JM, Aubier M: Diesel particles are taken up by alveolar type II tumor cells and alter cytokines secretion. Arch Environ Health 2002, 57:53-60.
104. Hoet PH, Nemery B: Stimulation of phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 2001, 176:203.
105. Lundborg M, Johard U, Lastbom L, Gerde P, Camner P: Human alveolar macrophage phagocytic function is impaired by aggregates of ultrafine carbon particles. Environ Res 2001, 86:244-253.
106. Mossman BT, Sesko AM: In vitro assays to predict the pathogenicity of mineral fibers. Toxicology 1990, 60: 3-61.
107. Oberdorster G: Lung particle overload: implications for occupational exposures to particles. Regul Toxicol Pharmacol 1995, 21:123-135.
108. Fernandez-Urrusuno R, Fattal E, Feger J, Couvreur P, Therond P: Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. Biomaterials 1997, 18:511-517.
109. Powell JJ, Ainley CC, Harvey RS, Mason IM, Kendall MD, Sankey EA, Dhillon AP, Thompson RP: Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 1996, 38:390-395.
110. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C: Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002, 65:1531-1543.
111. Pratten MK, Lloyd JB: Uptake of microparticles by rat visceral yolk sac. Placenta 1997, 18:547-552.
112. Alyaudtin RN, Reichel A, Lobenberg R, Ramge P, Kreuter J, Begley DJ: Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro. J Drug Target 2001, 9:209-221.
113. Pulfer SK, Ciccotto SL, Gallo JM: Distribution of small magnetic particles in brain tumor-bearing rats. J Neurooncol 1999, 41:99-105.
114. Schroeder U, Sommerfeld P, Ulrich S, Sabel BA: Nanoparticle technology for delivery of drugs across the blood-brain barrier. J Pharm Sci 1998, 87:1305-1307.
115. Kreuter J: Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001, 47:65-81.
116. Araujo L, Lobenberg R, Kreuter J: Influence of the surfactant concentration on the body distribution of nanoparticles. J Drug Target 1999, 6:373-385.